Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |